{"ticker": {"uuid": "c944ff79-a261-4bd5-bebf-536d997c8837", "symbol": "NVAX", "name": "Novavax Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology"}, "articles": [{"title": "Novavax (NVAX) Stock Sinks As Market Gains: Here's Why", "summary": "Novavax (NVAX) stock closed down 5.5% at $8.42, contrasting with general market gains. The company's shares also saw a 3.26% loss over the past month, while the Medical sector gained 4.34%. Analysts project a significant year-over-year decline in Novavax's upcoming earnings and r", "url": "https://finance.yahoo.com/markets/stocks/articles/novavax-nvax-stock-sinks-market-214503605.html", "source_name": "Market source", "published_at": "2026-07-14T21:45:00", "published_display": "14 Jul 2026 21:45", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Novavax Inc. stock underperforms Tuesday when compared to competitors", "summary": "Novavax Inc. (NVAX) stock fell by 5.50% on Tuesday, closing at $8.42, despite a generally positive trading day for the broader market. Both the NASDAQ Composite Index and the Dow Jones Industrial Average saw gains, highlighting Novavax's underperformance. This marked the third co", "url": "https://www.marketwatch.com/data-news/novavax-inc-stock-underperforms-tuesday-when-compared-to-competitors-0af7dd69-25354166ac60", "source_name": "MarketWatch", "published_at": "2026-07-14T17:27:00", "published_display": "14 Jul 2026 17:27", "sentiment": "negative", "sentiment_pct": 28, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Novavax Inc. stock underperforms Monday when compared to competitors", "summary": "Novavax Inc.'s stock (NVAX) fell 4.50% on Monday, closing at $8.91, amidst a general decline in the stock market. Both the NASDAQ Composite Index and the Dow Jones Industrial Average also experienced losses, with NVAX marking its second consecutive day of decline.", "url": "https://www.marketwatch.com/data-news/novavax-inc-stock-underperforms-monday-when-compared-to-competitors-949348ca-0b83dccd9d85?mod=mw_quote_news", "source_name": "MarketWatch", "published_at": "2026-07-13T17:28:00", "published_display": "13 Jul 2026 17:28", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Unpacking Q1 Earnings: Incyte (NASDAQ:INCY) In The Context Of Other Biotechnology Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMinAFBVV95cUxOZExLRk1BSFNPMnpMdEFEWjNtbWlkZUQ1aHJHZEtMZHJHZWZDZUI0ck1FM2JqWG9ncDRSNGxEWHZLemZualBEY3BVVzdiUmZiVmxqMFdnbEczbEpvTFBscnA3YVVMWmQ3TkFsVjBDZzl6VEZQanh1UkRaS2hiRTNPbGFwajRSV1A1amFKcnFhcFVITHdydjJpblVRTWI?oc=5", "source_name": "Market source", "published_at": "2026-07-13T12:30:39+00:00", "published_display": "13 Jul 2026 12:30", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Novavax Stock Hits Over 1-Year High: Is Sanofi\u2019s Flu-COVID Shot The Post-Pandemic Growth Driver?", "summary": "", "url": "https://news.google.com/rss/articles/CBMi4wFBVV95cUxPc0dRbnFaVW1wbHhjVTZvSHg4dm4wMjQ0RTloZEhsd1g4VllaTzgtejJNZ2M5QnlIZkpyNGlYM3ZkM2JiQzNMMnRKYk9OVWhwUkMxOWhabGlEVDFGTG9ER2FFQURqcmllRDQ4aDdyN2h2T09sSklrWmMwa0xiTDIyZVNyQ3NBLWVBd3ZZc3hNaVFvcTY2UTZia09xbHhiY0FQVUNsbVRWelhjeGpXdktmWk0yNG5mMkY1SDlYbUlNblhOX0ZOQVVvazhqak9IeXpOeGZScmFLRXRMUUdabDAtQ2lLcw?oc=5", "source_name": "Stocktwits", "published_at": "2026-07-12T20:19:35+00:00", "published_display": "12 Jul 2026 20:19", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Novavax options trading jumps to highest in months By Investing.com", "summary": "Novavax Inc. (NVAX) experienced a significant surge in options trading volume, reaching its highest levels in months on Friday. Call options hit a peak not seen since April 2024, while put options recorded their highest volume since December 2025, with two specific put options do", "url": "https://ng.investing.com/news/stock-market-news/novavax-options-trading-jumps-to-highest-in-months-93CH-2595332", "source_name": "Investing.com Nigeria", "published_at": "2026-07-10T17:44:00", "published_display": "10 Jul 2026 17:44", "sentiment": "negative", "sentiment_pct": 38, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Novavax options trading jumps to highest in months", "summary": "Novavax Inc. experienced a significant surge in options trading volume, with 13,629 contracts traded by Friday afternoon. Call options reached their highest level since April 2024, and put options saw their highest volume since December 2025. This increased activity was predomina", "url": "https://www.investing.com/news/stock-market-news/novavax-options-trading-jumps-to-highest-in-months-93CH-4786599", "source_name": "Investing.com", "published_at": "2026-07-10T16:41:07", "published_display": "10 Jul 2026 16:41", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Enterprise value to EBIT forward of Novavax, Inc. \u2013 BMV:NVAX", "summary": "This page from TradingView provides financial information for Novavax, Inc. (BMV:NVAX), specifically focusing on its enterprise value to EBIT forward. It indicates that the market is currently closed with no trades. The site also lists various other financial data, news, and comm", "url": "https://www.tradingview.com/symbols/BMV-NVAX/financials-statistics-and-ratios/enterprise-value-ebit-fwd/", "source_name": "TradingView", "published_at": "2026-07-10T14:41:07", "published_display": "10 Jul 2026 14:41", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Novavax (NVAX) Leaves Russell Growth Indexes, Is The 32% Undervaluation Case Convincing?", "summary": "", "url": "https://finance.yahoo.com/markets/stocks/articles/novavax-nvax-leaves-russell-growth-051516804.html", "source_name": "Simply Wall St.", "published_at": "2026-07-10T05:15:16+00:00", "published_display": "10 Jul 2026 05:15", "sentiment": "positive", "sentiment_pct": 58, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Novavax (NVAX) Dropped From Major Russell Growth Indices And Why It Matters", "summary": "", "url": "https://news.google.com/rss/articles/CBMioAFBVV95cUxOS2JoeHdWZWQ4T1VvU2N0RFRnNWZYaE1hODZTTURNbGdPSjBQejRCNHJ2Q0dkRHZ3THlHYlJFS2J6NnU2WTNHSi11R3R6ZXJxc1FwOGNlS0xKT1dyZVZDckc1VVVWT1NSNVRvalZYcGhaVnZCM3N0MFNydDRaanJKbWtEMjEtVXR6czRMVzh2MmFoN2U2MGprTEZSWW5rOEhh?oc=5", "source_name": "Market source", "published_at": "2026-07-10T03:24:00+00:00", "published_display": "10 Jul 2026 03:24", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Novavax Inc. stock outperforms competitors despite losses on the day", "summary": "Shares of Novavax Inc. (NVAX) fell 1.16% to $9.35, despite outperforming competitors on a mixed trading day where the NASDAQ Composite rose and the Dow Jones Industrial Average fell. The stock closed 21.89% below its 52-week high of $11.97, achieved on February 26th.", "url": "https://www.marketwatch.com/data-news/novavax-inc-stock-outperforms-competitors-despite-losses-on-the-day-1a5aa003-0d756f5efda7?mod=goog_fin_scmw", "source_name": "MarketWatch", "published_at": "2026-07-08T21:24:00", "published_display": "08 Jul 2026 21:24", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Novavax (NVAX) Suffers a Larger Drop Than the General Market: Key Insights", "summary": "Novavax (NVAX) experienced a larger daily drop of -1.16% compared to the S&P 500's -0.28%, despite recent gains in the Medical sector. The company is set to report earnings with a projected EPS of -$0.36 and revenue of $50.04 million, significantly down from the prior year. Howev", "url": "https://finance.yahoo.com/markets/stocks/articles/novavax-nvax-suffers-larger-drop-214502218.html", "source_name": "Market source", "published_at": "2026-07-08T17:45:00", "published_display": "08 Jul 2026 17:45", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 69, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Novavax Inc. stock underperforms Tuesday when compared to competitors despite daily gains", "summary": "Novavax Inc. (NVAX) shares increased by 1.18% to $9.46 on Tuesday, despite a general market downturn where the NASDAQ Composite fell 1.16% and the Dow Jones Industrial Average fell 0.25%. The stock is still 20.97% below its 52-week high of $11.97, reached on February 26th. This p", "url": "https://www.marketwatch.com/data-news/novavax-inc-stock-underperforms-tuesday-when-compared-to-competitors-despite-daily-gains-8ae5bd92-c8906c390031?mod=mw_quote_news", "source_name": "MarketWatch", "published_at": "2026-07-07T17:26:00", "published_display": "07 Jul 2026 17:26", "sentiment": "negative", "sentiment_pct": 39, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Novavax Inc updates Covid-19 vaccine plans as investors weigh long-term prospects", "summary": "Novavax Inc is adjusting its Covid-19 vaccine strategy, focusing on updated formulations and potential combination vaccines, as it navigates the shift from emergency pandemic demand to a more regular, seasonal vaccination market. Investors are closely watching regulatory decision", "url": "https://www.ad-hoc-news.de/boerse/news/ueberblick/novavax-inc-updates-covid-19-vaccine-plans-as-investors-weigh-long-term/69715214", "source_name": "AD HOC NEWS", "published_at": "2026-07-07T15:13:57", "published_display": "07 Jul 2026 15:13", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "regulatory", "event_label": "Regulatory and legal", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Novavax, Inc. (NVAX) Is a Trending Stock: Facts to Know Before Betting on It", "summary": "Novavax (NVAX) has been a highly searched stock recently, with its shares returning +8.5% over the past month. The company currently holds a Zacks Rank #1 (Strong Buy), indicating potential near-term outperformance based on positive earnings estimate revisions. Despite this, proj", "url": "https://sg.finance.yahoo.com/news/novavax-inc-nvax-trending-stock-130006050.html", "source_name": "Market source", "published_at": "2026-07-07T13:13:57", "published_display": "07 Jul 2026 13:13", "sentiment": "positive", "sentiment_pct": 64, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Does Novavax\u2019s (NVAX) Russell Exit Quietly Recast Its Partnership-Driven, Royalty-Focused Equity Story?", "summary": "Novavax (NVAX) was removed from several Russell growth indices on June 27, 2026, which may influence institutional investor behavior. This expert analysis explores how the index removal could reshape the perception of Novavax's partnership-driven, royalty-focused business model, ", "url": "https://www.sahmcapital.com/news/content/does-novavaxs-nvax-russell-exit-quietly-recast-its-partnership-driven-royalty-focused-equity-story-2026-07-05", "source_name": "Sahm", "published_at": "2026-07-07T06:39:56", "published_display": "07 Jul 2026 06:39", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "If You Invested $1,000 in Novavax Inc (NVAX)", "summary": "This article analyzes the historical performance of investing $1,000 in Novavax Inc (NVAX) over 1, 5, and 10 years, detailing significant fluctuations including a +2383.5% return in 2020 and sharp declines in other years. It also provides an overview of Novavax as a biotechnology", "url": "https://www.stocktitan.net/tools/stock-return-calculator/NVAX", "source_name": "Stock Titan", "published_at": "2026-07-06T03:10:16", "published_display": "06 Jul 2026 03:10", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Novavax stock holds the focus as investors await the next catalyst.", "summary": "Novavax (NVAX) stock remains a Nasdaq-listed vaccine company, with its shares primarily influenced by updates on commercialization, regulatory progress, and cash utilization. The article emphasizes that future market reactions will likely stem from company updates regarding deman", "url": "https://www.ad-hoc-news.de/boerse/news/ueberblick/novavax-stock-holds-the-focus-as-investors-await-the-next-catalyst/69680115", "source_name": "Ad-hoc-news.de", "published_at": "2026-07-03T13:40:11", "published_display": "03 Jul 2026 13:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "regulatory", "event_label": "Regulatory and legal", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Novavax (NVAX) Stock Moves 1.36%: What You Should Know", "summary": "Novavax (NVAX) stock recently moved up 1.36%, closing at $9.59. This movement contrasts with a prior 7.25% loss over the past month for the vaccine maker. Analysts anticipate a significant year-over-year decline in earnings and revenue for Novavax's upcoming report and the full y", "url": "https://finance.yahoo.com/markets/stocks/articles/novavax-nvax-stock-moves-1-214503068.html", "source_name": "Market source", "published_at": "2026-07-02T21:39:19", "published_display": "02 Jul 2026 21:39", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Novavax Inc. stock underperforms Thursday when compared to competitors despite daily gains", "summary": "Novavax Inc. (NVAX) shares gained 2.96% on Thursday, closing at $9.74. Despite this daily increase, the stock underperformed compared to its competitors, even as the Dow Jones Industrial Average rose. This marked the fifth consecutive day of gains for Novavax stock.", "url": "https://www.marketwatch.com/data-news/novavax-inc-stock-underperforms-thursday-when-compared-to-competitors-despite-daily-gains-fa8f491d-5a7723161bbe?mod=mw_quote_news", "source_name": "MarketWatch", "published_at": "2026-07-02T17:24:00", "published_display": "02 Jul 2026 17:24", "sentiment": "positive", "sentiment_pct": 60, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "(NVAX) as a Liquidity Pulse for Institutional Tactics", "summary": "This article analyzes Novavax Inc. (NASDAQ: NVAX) with a strong overweight bias based on robust sentiment across all time horizons. It highlights an exceptional 58.0:1 risk-reward setup, targeting a significant gain for investors. The analysis includes institutional trading strat", "url": "https://news.stocktradersdaily.com/news_release/91/NVAX_as_a_Liquidity_Pulse_for_Institutional_Tactics_070126070202_1782946922.html", "source_name": "Stock Traders Daily", "published_at": "2026-07-01T19:02:00", "published_display": "01 Jul 2026 19:02", "sentiment": "positive", "sentiment_pct": 80, "event_type": "liquidity", "event_label": "Balance sheet", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "ETFs Investing in Novavax, Inc. Stocks", "summary": "This article lists various ETFs that include Novavax, Inc. (NVV1) stocks in their holdings. The ETFs are sorted by market value and provide data such as market value, weight of NVV1 in the ETF, issuer, management style, focus, expense ratio, AUM, price, change, relative volume, a", "url": "https://www.tradingview.com/symbols/BX-NVV1/etfs/", "source_name": "TradingView", "published_at": "2026-06-29T19:10:43", "published_display": "29 Jun 2026 19:10", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Novavax Inc. stock outperforms competitors on strong trading day", "summary": "Novavax Inc. (NVAX) shares rose 5.41% on a strong trading day, closing at $9.36. This performance outpaced the broader market, with the NASDAQ Composite Index and Dow Jones Industrial Average also seeing gains. This marks the second day of consecutive gains for Novavax stock.", "url": "https://www.marketwatch.com/data-news/novavax-inc-stock-outperforms-competitors-on-strong-trading-day-5ea99820-3c8e90419cd3?mod=goog_fin_scmw", "source_name": "MarketWatch", "published_at": "2026-06-29T17:29:00", "published_display": "29 Jun 2026 17:29", "sentiment": "positive", "sentiment_pct": 70, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Novavax, Inc.(NasdaqGS: NVAX) dropped from Russell 3000E Growth Benchmark", "summary": "Novavax, Inc. (NasdaqGS: NVAX) has been removed from the Russell 3000E Growth Benchmark. This news comes amidst other recent company updates, including presentations at healthcare conferences and its first-quarter 2026 earnings report, which showed narrower-than-expected net loss", "url": "https://www.marketscreener.com/news/novavax-inc-nasdaqgs-nvax-dropped-from-russell-3000e-growth-benchmark-ce7f5fdedb81f326", "source_name": "www.marketscreener.com", "published_at": "2026-06-29T03:13:04", "published_display": "29 Jun 2026 03:13", "sentiment": "negative", "sentiment_pct": 33, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Novavax boosts efficiency and productivity with ServiceNow", "summary": "Novavax partnered with NTT DATA to upgrade its ServiceNow platform, aiming to improve operational efficiencies and accommodate rapid growth, particularly following the success of its COVID-19 vaccine. The transformation involved upgrading to the \"Tokyo\" release, establishing a co", "url": "https://www.nttdata.com/en-us/insights/case-studies/novavax-boosts-efficiency-and-productivity-with-servicenow", "source_name": "NTT Data", "published_at": "2026-06-27T02:40:47", "published_display": "27 Jun 2026 02:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Enterprise value to revenue forward of Novavax, Inc. \u2013 SIX:NVAX", "summary": "This article briefly reports on the enterprise value to revenue forward for Novavax, Inc. (SIX:NVAX). It provides basic financial data and links to various tools and resources available on the TradingView platform related to market analysis. The content is sparse, primarily focus", "url": "https://www.tradingview.com/symbols/SIX-NVAX/financials-statistics-and-ratios/enterprise-value-sales-fwd/", "source_name": "TradingView", "published_at": "2026-06-27T02:38:59", "published_display": "27 Jun 2026 02:38", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "How Investors May Respond To Novavax (NVAX) Shareholder Revolt Over Pay And Board Governance", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-06-26T22:17:30+00:00", "published_display": "26 Jun 2026 22:17", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Enterprise value to EBITDA forward of Novavax, Inc. \u2013 SIX:NVAX", "summary": "This article examines the enterprise value to EBITDA forward for Novavax, Inc. (NVAX) on the SIX Swiss Exchange. It provides financial transparency but does not offer specific values or analysis. The brief page is part of a larger financial data platform.", "url": "https://www.tradingview.com/symbols/SIX-NVAX/financials-statistics-and-ratios/enterprise-value-ebitda-fwd/", "source_name": "TradingView", "published_at": "2026-06-26T22:40:06", "published_display": "26 Jun 2026 22:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Novavax Inc. stock underperforms Friday when compared to competitors despite daily gains", "summary": "Novavax Inc. (NVAX) shares rose 3.74% on Friday, closing at $8.88, despite a broader market downturn with the NASDAQ Composite and Dow Jones Industrial Average both falling. This gain ended a two-day losing streak for Novavax, though the stock was noted to underperform when compa", "url": "https://www.marketwatch.com/data-news/novavax-inc-stock-underperforms-friday-when-compared-to-competitors-despite-daily-gains-ce1685b1-20db0dc452a3?mod=mw_quote_news", "source_name": "MarketWatch", "published_at": "2026-06-26T21:40:05", "published_display": "26 Jun 2026 21:40", "sentiment": "negative", "sentiment_pct": 40, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Enterprise value to revenue forward of Novavax, Inc. \u2013 NASDAQ:NVAX", "summary": "This article focuses on the enterprise value to revenue forward metric for Novavax, Inc. (NASDAQ: NVAX). The provided content is from TradingView and includes financial data and stock market information for the biotechnology company.", "url": "https://www.tradingview.com/symbols/NASDAQ-NVAX/financials-statistics-and-ratios/enterprise-value-sales-fwd/", "source_name": "TradingView", "published_at": "2026-06-26T20:40:06", "published_display": "26 Jun 2026 20:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Investors Heavily Search Novavax, Inc. (NVAX): Here is What You Need to Know", "summary": "", "url": "https://news.google.com/rss/articles/CBMiowFBVV95cUxNNXU5a3RtLWNhaTR0dVVzczlGdGRnLWdQQlM1MzQ1WlFYeVRvejNmeXNzVkdoNGZtNXU1TVAzYkxJZU9Pb2F6SU1KQkhnU0s5Ym5MUzVYRnpzRWowVkh2Z1JtM05oam00Q2txZ1h3ZXBQRE5lRHgyUEd3b0pxLTZvWm5xNHV5QkttUHd4eURjMnhWQ056Z0ZOWDB0Z1dtTkpIQjRJ?oc=5", "source_name": "Market source", "published_at": "2026-06-23T07:00:00+00:00", "published_display": "23 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Novavax (NVAX) Stock Falls Amid Market Uptick: What Investors Need to Know", "summary": "", "url": "https://news.google.com/rss/articles/CBMimgFBVV95cUxNR0R0NjJoYUc5ZnZRLXFBZGRJSzJsS25udDFjOVBsX2l1bmIyLVFMX2xWNjZoTzBpY21JWUFFb2M4aElUUFVkTGFpdXl6SWUta3M2dHpvTEl4cHJfSTBVN0p3Q3d0RGY2TnJ5QW5iU2dGTmU5dHJ5MXZ0SDdUNHJVdnVHbmZMSGJUeWF4TXdqdXdQS3lOcnNaOUxn?oc=5", "source_name": "Market source", "published_at": "2026-06-18T07:00:00+00:00", "published_display": "18 Jun 2026 07:00", "sentiment": "negative", "sentiment_pct": 22, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Novavax (NVAX) Stock Slides as Market Rises: Facts to Know Before You Trade", "summary": "", "url": "https://news.google.com/rss/articles/CBMingFBVV95cUxPU3Q1eE5WdXBtNjdhR2daMzljZ3ZObE4tSmJCNlhfYWtwamdySl91eTF4eENQQ3dVTFZZRlg1Q3c5WmFtUG04UzZtVjRnY1FscnJvSC1IV0FFV21NN09DMUlMcGxMMEYxc1dKVXN4NDIwa3JHdjUycHEyeXJwMDFjR0ZOQklibkRBM0tfbTBRckxxMDBwajc0dTdwZGJVUQ?oc=5", "source_name": "Market source", "published_at": "2026-06-12T07:00:00+00:00", "published_display": "12 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Novavax Inc stock (US6707721049): Analyst consensus points to hold as NVAX trades near 11 USD", "summary": "", "url": "https://news.google.com/rss/articles/CBMiygFBVV95cUxPNExjdEtwQVR4Q1RmeUdIM0JOdmhLenRfVXBvWTc1T0Mta1Q0T2ZNTm5WRVVSSFp3SmpnUDNNWU1nd0VFejVsWldLV1phdV9uY05vMmxqZGJKazRGSFZCTk1fVlhJQlVuMGRyMXFyUDdiYUM1VGVOS09Vbmw2U0p6b2NwRXItUU9rbmd2MThaaDVfcExwWmtwS0RUa2wyVEhFSVhGc3NFcGV2ZHR5cTVxOGpHZllYTkFXY3Uzb1hzYUNrcVEycHlyYmhn?oc=5", "source_name": "Ad Hoc News", "published_at": "2026-06-01T07:00:00+00:00", "published_display": "01 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Novavax Inc stock (US6707721049): shares trade around USD 10 after recent volatility and licensing f", "summary": "", "url": "https://news.google.com/rss/articles/CBMiyAFBVV95cUxOLVE5bWJUcHlrUHFlVkpDN1UwcWFjYWViNFNEZTA1S0kxSEt5dVR1OFBTeDhuZk11RUNyNjFHSWJnYXlNdERTNEVrZzhMcmJCcUtBRnRTcVUwTkdDcTJZdHdzMkN0OG9LS1dqOTVyWWFBTUNGbERVck9wNW5lU1JzUXEycDBpT3lvdENPVWNNdndDdmdlZWo2YVlORlVwS2xjMGZ4aXlqb0dlWkZSN3hZeWZZTmtteURJWDBFS0ExNTlsYVZ0eVFNSQ?oc=5", "source_name": "Ad Hoc News", "published_at": "2026-05-29T07:00:00+00:00", "published_display": "29 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Novavax Inc stock (US66987V1098): NVAX trades at $11.09 on Nasdaq", "summary": "", "url": "https://news.google.com/rss/articles/CBMivAFBVV95cUxPclBSWnlWa18tSkM0cTRTZGlqLVUyV0U4Y1I5LTBieU0xTEtxdEdsYkxsWndUdlpmd1duLV9pZHNsT0JEbllIRTI1U1V0Q0hEN3dwUFotb0VVWHNHRDUxZGNiWXE0R29uTFRqMGdtWVFmSkJ3WWVQY2JYaXdpMDI3aTN1SlF3b1RTMnVtSXpwd2xRenRiaFNiRnVzZk9YNHV4b2ZDc3ZUTzlMTGhGNE9aNFdGa0ZKaldTeDN2aQ?oc=5", "source_name": "Ad Hoc News", "published_at": "2026-05-28T07:00:00+00:00", "published_display": "28 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Why Novavax (NVAX) Stock Is Trading Up Today", "summary": "", "url": "https://news.google.com/rss/articles/CBMimwFBVV95cUxPeElVSURka1VqSl94NEhLNUM2MDhpV3d4MkZpS3RPbWNaSjF5QVhSS21STDRRNFZZck9DSnNranhXRklnenF3dW5neDFON2tsdW1JUmxwMzFaUzlwWFRqZ3FMVV82eDVMYzAzWUF0N3VLSmhnYndST21BN1NTa2poVm95MHhoRU5HWjNHR1ZjcW9SdjhYODVDZkdSSQ?oc=5", "source_name": "Market source", "published_at": "2026-05-26T07:00:00+00:00", "published_display": "26 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Novavax Inc stock (US66987V1098): earnings volatility and Covid-vaccine hopes in focus", "summary": "", "url": "https://news.google.com/rss/articles/CBMixgFBVV95cUxQRGpPRGNaOWE3bXFiZUZMaWZ5ZmNlZ1ZPdUdMYkRvLWE5alI5MXdRSnZaQXlQckNTTUMtYlNyVGlIc1VpMTJNMmN3RWxJUU83anZPQkRLRHdUTjJmRWxjd3kzdk1QTTRKcklIcGRGU1N4bjZ4Y3FVZTR2eTh4c2w1UUlZYlYxLVF5M0dzbHdQdTlNYVV2OGZZZ1ZuRmxHUWlsSGgzU0lJMGNTSEVFX2tCMGgzRnVaWkZNaGhtUFVNUVI4RFVkT0E?oc=5", "source_name": "Ad Hoc News", "published_at": "2026-05-17T07:00:00+00:00", "published_display": "17 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "There May Be Reason For Hope In Puma Biotechnology's (NASDAQ:PBYI) Disappointing Earnings", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-05-15T07:00:00+00:00", "published_display": "15 May 2026 07:00", "sentiment": "negative", "sentiment_pct": 34, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Novavax stock (US66987V1098): Latest developments and business update", "summary": "", "url": "https://news.google.com/rss/articles/CBMiwwFBVV95cUxNZmlwR0JCT2hid25JV1VkeVNBU3JwUWF6UlpQSURnNndaNXNGS1dvaTdxZTNtNWNKcDlXNlp2OTVVTzkzN3lOeTlfRC15eVVUdFd3dVhjODRqN3B0SUdHaVBlaktXNXdyOGNRYmJvR014T25mSjlWSFlsS1hLLW1HNjl0amhYMWlkQ2tDZ3FzdmNmVEp5SEM4QnhUVS02WjY2NHhZUGdlb19OUzY5b0hTaGpTUkVjT183Q2cxSU1OaXhVT3c?oc=5", "source_name": "Ad Hoc News", "published_at": "2026-05-14T07:00:00+00:00", "published_display": "14 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Puma Biotechnology's (NASDAQ:PBYI) Conservative Accounting Might Explain Soft Earnings", "summary": "", "url": "https://news.google.com/rss/articles/CBMirgFBVV95cUxNZXcyN1VKc0J0RTFtSER6TGRSZm8xSWs2c0paem5paDd3V0J1cjF6ajhFb29tRFpUWWpxYUhzZjFkSXhYQ0lBNTVlbTdCRERpSXNjaGpDajFPOVlpRS1qV2xHMTRHS2pjVVBZMWFfNzItWE9FeENtQ2duMUxVQm5kOG41eVlrNUpObXp2VlhfekdhMVh2X0hjN3ZFZThZNUdWakFLUXJ4aFBVN2JyR2c?oc=5", "source_name": "Market source", "published_at": "2026-05-14T07:00:00+00:00", "published_display": "14 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Puma Biotechnology, Inc. (NASDAQ:PBYI) Analysts Are Pretty Bullish On The Stock After Recent Results", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-05-11T07:00:00+00:00", "published_display": "11 May 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Earnings Update: Here's Why Analysts Just Lifted Their Puma Biotechnology, Inc. (NASDAQ:PBYI) Price Target To US$5.00", "summary": "", "url": "https://news.google.com/rss/articles/CBMingFBVV95cUxPSUN3RjZYMEJ2VUdKQjJpRkZaUXRzM2NTa05WWmlmWHJnZDlJeUpTdFM5Wmk0SUhjclU2dldTZFIyRmZZeGJSNGM2SUNiSGJSYjh1VjYyR0hPZ2FJbWdsbHExYlhwMW1HRTZ0NUxwQzU1b2g4MGpwSHdoMkdIOUtqOXBBYk92LVk2cEFZMzVISjB3c04ydVBEYWw2cVVsdw?oc=5", "source_name": "Market source", "published_at": "2026-05-11T07:00:00+00:00", "published_display": "11 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Novavax (NASDAQ:NVAX) Surprises With Strong Q1 CY2026, Stock Soars", "summary": "", "url": "https://news.google.com/rss/articles/CBMiowFBVV95cUxQQUVPRXZYeS1UaE5JYmRiR0tINk9hVFFnTG1NTHBkSlNsVW1pN3RlclBzQW50MXZLTzBwRDkxenBnQlZDU1A1UWNlTWluSDRUMm1pVHFSamtxTEMzOVFzNi1wQTAxTWRhRnU4YkJEY0FwemR6d25vc3ZWTEZwN19XYzZBUURGM3h3QjBla29ETE12NjE5N3BEUmxxdjYzZVN2dlow?oc=5", "source_name": "Market source", "published_at": "2026-05-06T07:00:00+00:00", "published_display": "06 May 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Is It Time To Reconsider Novavax (NVAX) After A 95% Five Year Share Price Fall", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-05-05T07:00:00+00:00", "published_display": "05 May 2026 07:00", "sentiment": "negative", "sentiment_pct": 34, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Is Novavax, Inc. (NVAX) A Good Stock To Buy Now?", "summary": "", "url": "https://news.google.com/rss/articles/CBMilwFBVV95cUxQUk1xRnVDRTlqZVBLMHFCUjdhcTVwckFDWWo1VWx4emZmUDVqcEhET0c1VjFnYzhlaFByU1p3VW1pbFVQcW16YTNaSzQzVGEybkR1X3ZFSGNia0NVS0w5Y3lpSlRFTGdiZnFwWHRxQTVmQ1p1elNqYTVjRnJycmUzQ2VraTR6MDJycXBVRVk5UGs4UnpYTEY0?oc=5", "source_name": "Market source", "published_at": "2026-04-30T07:00:00+00:00", "published_display": "30 Apr 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Q4 Earnings Highlights: Regeneron (NASDAQ:REGN) Vs The Rest Of The Biotechnology Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMirAFBVV95cUxNWW9GYm5uRzlBX2ZiZXA3RkdDXzJhaFd2N1ZwR21jaXhiRkZQSTNHT0hMaUFjSGl6VXZfOURKemF2bWlFS1hKTXBjZUw4amdVQ0I4QlVnNmFkY1VTQ25pUjBiZGNDUE9QdWdOZHAxV1I1ejN6UE9WdGpseUdrMVA5MXBXWXJmWDBkZUdWUkxpOURCdlZlbDlQR3M5cjAzaDFtakFNblRTa3c0Q1J6?oc=5", "source_name": "Market source", "published_at": "2026-04-25T07:00:00+00:00", "published_display": "25 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Biotechnology Stocks Q3 Results: Benchmarking Natera (NASDAQ:NTRA)", "summary": "", "url": "https://news.google.com/rss/articles/CBMiswFBVV95cUxPZzZDSEhwNlVYQU9kNXBMMU5ia0FTU0RxRlYwb0I1RERNODN4N0VwRFZWMUY4ODh3eWNkTkp0UERreFlSTllocGk4a2ZKcGlJVjQ4d1dXWlNnYTc5UlNMZm4wc2xITjRQVzhRb3Z5LXllQmhvUHNIaXB3LXk1RUw1WnRPam9wcVE1MXFxSmVzVF9MVmRyMWIwdVkxS1N3MUJZUzByLWxrVDlSSUk4QnNsXzJYbw?oc=5", "source_name": "Market source", "published_at": "2026-04-21T07:00:00+00:00", "published_display": "21 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Novavax (NVAX) Beats Stock Market Upswing: What Investors Need to Know", "summary": "", "url": "https://news.google.com/rss/articles/CBMinAFBVV95cUxQaHAwQ0RVN181VEpKMUo2WUZteDhPUm82TDFnbzFoVHBVVnhxbkhrT2h0aGFNM1AwMkpmRFVvbUgxM2xzVjRaOXlhNFk5Z1NRaEtUVmNZcjlJM3lHRldxczJvRWZhektZcnlGdWdsYVdWVE9wN1N2dVlUY3dUcGVpRU13RnpQcHdsZ21PZ3ZTdmdqZmNQaDZFSTZhbFA?oc=5", "source_name": "Market source", "published_at": "2026-04-09T07:00:00+00:00", "published_display": "09 Apr 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "AMN Healthcare Services, DaVita, Bristol-Myers Squibb, Novavax, and AbbVie Shares Plummet, What You Need To Know", "summary": "", "url": "https://news.google.com/rss/articles/CBMi-gFBVV95cUxPZmJKQ3l2S2FkYjlsd0xiQWUwX1V5d3R2cEMzblBrVmNTUEdtdWFndkl6UnAyOTVQYW96VGdiQzlaX3dwQ0FjSUNHVE9mSy1kLTlhX29HUmFfcG55ZlRRV2lfcGl2S2l5ZXc0TUZwcmFxRGFHVjJyWW9EMXk4UVFWRUxQMEZybElFTll6NjNsNUxKcUJ6cEE2aTZPYXpMYXhYRm51LTRlRHp2RXIzQjFfSG1Wc3pVcFkyRVZaUjduTjFOWlZ5TmV1Q1VKWUdPREtlbW5sX3c3MkltOWVXRWlHMEdUSnBBTllFRjQ3bFkwSndnc2FiZFlkOHhB?oc=5", "source_name": "StockStory", "published_at": "2026-04-02T07:00:00+00:00", "published_display": "02 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "A Look Back at Biotechnology Stocks\u2019 Q4 Earnings: Incyte (NASDAQ:INCY) Vs The Rest Of The Pack", "summary": "", "url": "https://news.google.com/rss/articles/CBMi5gFBVV95cUxNWEtsYkktQkxQRHpTMHJOZzJaN09fT3R5aUpjZ0xEQTZXZGlCVUk0alZrVXhIRERNOW9feVJ1X0R4VUI2Q0FjUGIwTWpIRXE2dXpCLW9NdVdoSEE5b0JEM18wN2FQSGdXMDZfOGJ3STJPUmQ2VVBIbUQ5djhTZ01RTmpxLTdKRmdhN0U3RE52N0dEUzh4VFZ5c3dDd0ppZ1VYeGc0Mm5oQlU5TGJlQldpVHpoVjlhdXZ6ek0yaTBuQV9UUjNFT19kWFZ4QVViODkwN2ppOFRQU3lHQ1IxdXhrRkFGS3E0QQ?oc=5", "source_name": "TradingView", "published_at": "2026-03-29T07:00:00+00:00", "published_display": "29 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Reassessing Novavax (NVAX) After Recent Share Price Rebound And Valuation Signals", "summary": "", "url": "https://news.google.com/rss/articles/CBMiiwFBVV95cUxPa0g1TTk2RjU0X3FEdGcxTjJpWDhzQ04ydzZ0SEt3c0FMTm4zdWM2RzdNOUFYanFHb3kzZXhpQlBmbjZ3TXIyWVo2WDdYQ3ZycmtTS0Zya3oxR1VDS1BiYWFGYTRyYTZ4dFZjV19tbXg4OXozcHQ3RHlKb3REY2dYa3M2VmRmVUt6aWIw?oc=5", "source_name": "Market source", "published_at": "2026-01-23T08:00:00+00:00", "published_display": "23 Jan 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Novavax Pfizer Licensing Deal Puts Matrix M And Valuation In Focus", "summary": "", "url": "https://news.google.com/rss/articles/CBMi2AFBVV95cUxPWThiUkJud254dEJKaHhqVnhOQ0Y1NUJ2aFFTaC1KUGlnUjkzdldIZWg1MFN6QldBYU1oQkxmNDg0N2c0TkEwSXRTSER0N1Y1UXFjUXoyZDhSUUpVU1h3VGZoMWt0UjAyVGZ4TDdWWVUyZW9LV3hmTDJjckYtY1dLcTNyTGhoblFNNG4yZks1eVJZb1BjelMxaWJyaWFXQXJZM1ZMaXFKVGFoRkt0eHpoS0RRUmdpY2FPTkt0UzI4cGFFb1JaN1ptY0lMU0hqQk1udUxZLV9lSkbSAd4BQVVfeXFMUGZsOFJJOWhMYkxRQUFWVmtKU3JRT1hOSy1pMEZBUVFUYlBWczREWGgyYVQ1Z0RDQnk3LURFR2R3SGlaZk1KZWdOZzdSSjBHSTdBZW4yaF9BeTg3MmNaYUlKYktvTjY2cGNGZVJpNWlqZExNeEtxdFRDb21lUzRQYXp1OWZUTS0zMkkzeEpWYXNNR2tsczRWMWZBdjBDTnc4MmJNdUhUazZOS2RwZUZLNGlXcmhQTlc3VjlMMDV5LXBjeUxYVmxMdHlqZnVFZ0NYZ1I0UFE5Z1ptYkR6Q19B?oc=5", "source_name": "simplywall.st", "published_at": "2026-01-22T08:00:00+00:00", "published_display": "22 Jan 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Improved Revenues Required Before Novavax, Inc. (NASDAQ:NVAX) Stock's 32% Jump Looks Justified", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-01-14T08:00:00+00:00", "published_display": "14 Jan 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Novavax, Inc.'s (NASDAQ:NVAX) latest 12% decline adds to one-year losses, institutional investors may consider drastic measures", "summary": "", "url": "https://news.google.com/rss/articles/CBMi2AFBVV95cUxNSnQ5UWQteFhYbXJjSzRqZUpweGQ2czJOVTBKTGdla3dSSUV0WkJYdEtkNVpaTThwWEdZbWtWSGNNS055ZTFfZ2NOQXQ0ZlFsSG1zSFlPeGhRVWVHYWEtUWxUSE13V09PMm91WkFnZ1VScmtObFFPWVBkbE9RS3JpUFBHRldnOUkzazFHeXVXT1A5eXc2eXdmaVpZV2E3SjdEQWlVMFdXUmtLUFlFME9YZHRsXzNacmhXbzUzNjRtMUF3eU1mS1NwT2E3UHJnZ1BjZGIyZXUxek_SAd4BQVVfeXFMT3ZhNlVRM2lUd0JrcXQtYm4zZ25EOGhWNEM3NVNHS0ZSWUY2NVNualozZjRPSHRhNVZaWlAyYXlhdlpVTmFBbWRNNXFnXzItV05CNzNSN2NFTjRxTE1ER2VLVFg1UVQ1WjhaRHJ4MFFhLTV0eEJtM1FMQnBTaFhOYU9pLUxNTHc2VEtuM3FLQkxWZXNQTkVVOXZ4VVRsT051YndtOFVDMkpNUC1sRDFzYXRSU0w2MFF4amM1b3lYZERDbm9meW9OSmpydWYzM0cwb3pRZXJhbndvajhVbF9n?oc=5", "source_name": "simplywall.st", "published_at": "2025-08-03T07:00:00+00:00", "published_display": "03 Aug 2025 07:00", "sentiment": "negative", "sentiment_pct": 18, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Novavax sinks on concerns about COVID vaccine maker's prospects", "summary": "", "url": "https://news.google.com/rss/articles/CBMivgFBVV95cUxNOVFTcHhvcUQ5YTd5cFpzNXBWcjJvZUZldlptdjNSMkxQZHItRUM4RGlnbEt0MTVuUjN6RnZaQ2dMdzFjSDUwVWt5ZklObERVU1p0X2x5cHMwb1JBWHBwdmVjaGF3a2dJNUUwdXF4Qk1jZi1JcVFsREROMXhGVDAtMWZWeVVIRkRkZUFiNldLYjE2R0xsbjhOa2VMelpMMlVGd0NERkY0a0ljQ21iZ3QwZ292MjJ2blctc05lcU9n?oc=5", "source_name": "Reuters", "published_at": "2023-03-01T08:00:00+00:00", "published_display": "01 Mar 2023 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Novavax confident Covid vaccine will receive FDA authorization in June after delays", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "CNBC", "published_at": "2022-05-13T07:00:00+00:00", "published_display": "13 May 2022 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "COVID-19 vaccinemaker Novavax faces manufacturing setback", "summary": "", "url": "https://news.google.com/rss/articles/CBMingFBVV95cUxOeEJNQUIzWjBEREF3em1Sc2k3ZzBQMTdsRWtkZWZsTEpFT0NsWnMxMmlVMU51NWJ4bGs0TjhnNk1aMHp5M0k3NVNVWnRITldLMm56X0NQcFVobFJmYUNac1BmalN4VEJtem5zTFpfM1BOVFBkbHZ5TXRCLVRiZVpDbW0zZ0lTSEpjRzQwNC16LVZFZzZ6dmxKZ3gxbTZoQQ?oc=5", "source_name": "Science | AAAS", "published_at": "2021-08-06T07:00:00+00:00", "published_display": "06 Aug 2021 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "After a Rocky Start, Novavax Vaccine Could Be Here by Summer (Published 2021)", "summary": "", "url": "https://news.google.com/rss/articles/CBMib0FVX3lxTFBrOTVsT3RUTmxseDVIWUFabzI4NFJyUnpHbHlCR19WUTlJWHJBRldUY2FnVGhYY0JXT1hLZ3ZiMmUxTUcyT1VzV3Bmb2I1ME9CZklBQ0Q0akhueEduZFpvbS11d2U0ZEZNdTkyRXNMOA?oc=5", "source_name": "The New York Times", "published_at": "2021-02-04T08:00:00+00:00", "published_display": "04 Feb 2021 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Novavax bosses cash out for $46 million with COVID-19 vaccine trials still under way", "summary": "", "url": "https://news.google.com/rss/articles/CBMi9AFBVV95cUxNQl9FU2RJWGUzTlp0UUdudVRWd3p1Wml0MnViQ0U5ZnJ3czVWU1p4NWRHTGU2eUJScGpQMmVtVGxYSENXSTkwRUtkODJBeWREallpQWhLeUxDSklZdnUzMTE2TDUwV2pvdE96WWdSQllXd3RPVEtwOTF3VFZaX0tjcUF3Z2tnTjV5dEN0c3c5Z1JyRlVyamZDcm1JSXVLQ3lGejV3MDExYnZWbUVYYWFHMW5nakN6ZGpiU1JHcnM1czlyZzNFNHJIa0tMNkdSRHMybWF2dVJFTEc0am9GNi16aTFNdFFVYnotU3phcGRzX1QwYkho?oc=5", "source_name": "Reuters", "published_at": "2021-01-11T08:00:00+00:00", "published_display": "11 Jan 2021 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "liquidity", "event_label": "Balance sheet", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}], "by_tier": {"direct": [{"title": "Novavax (NVAX) Stock Sinks As Market Gains: Here's Why", "summary": "Novavax (NVAX) stock closed down 5.5% at $8.42, contrasting with general market gains. The company's shares also saw a 3.26% loss over the past month, while the Medical sector gained 4.34%. Analysts project a significant year-over-year decline in Novavax's upcoming earnings and r", "url": "https://finance.yahoo.com/markets/stocks/articles/novavax-nvax-stock-sinks-market-214503605.html", "source_name": "Market source", "published_at": "2026-07-14T21:45:00", "published_display": "14 Jul 2026 21:45", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Novavax Inc. stock underperforms Tuesday when compared to competitors", "summary": "Novavax Inc. (NVAX) stock fell by 5.50% on Tuesday, closing at $8.42, despite a generally positive trading day for the broader market. Both the NASDAQ Composite Index and the Dow Jones Industrial Average saw gains, highlighting Novavax's underperformance. This marked the third co", "url": "https://www.marketwatch.com/data-news/novavax-inc-stock-underperforms-tuesday-when-compared-to-competitors-0af7dd69-25354166ac60", "source_name": "MarketWatch", "published_at": "2026-07-14T17:27:00", "published_display": "14 Jul 2026 17:27", "sentiment": "negative", "sentiment_pct": 28, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Novavax Inc. stock underperforms Monday when compared to competitors", "summary": "Novavax Inc.'s stock (NVAX) fell 4.50% on Monday, closing at $8.91, amidst a general decline in the stock market. Both the NASDAQ Composite Index and the Dow Jones Industrial Average also experienced losses, with NVAX marking its second consecutive day of decline.", "url": "https://www.marketwatch.com/data-news/novavax-inc-stock-underperforms-monday-when-compared-to-competitors-949348ca-0b83dccd9d85?mod=mw_quote_news", "source_name": "MarketWatch", "published_at": "2026-07-13T17:28:00", "published_display": "13 Jul 2026 17:28", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Novavax Stock Hits Over 1-Year High: Is Sanofi\u2019s Flu-COVID Shot The Post-Pandemic Growth Driver?", "summary": "", "url": "https://news.google.com/rss/articles/CBMi4wFBVV95cUxPc0dRbnFaVW1wbHhjVTZvSHg4dm4wMjQ0RTloZEhsd1g4VllaTzgtejJNZ2M5QnlIZkpyNGlYM3ZkM2JiQzNMMnRKYk9OVWhwUkMxOWhabGlEVDFGTG9ER2FFQURqcmllRDQ4aDdyN2h2T09sSklrWmMwa0xiTDIyZVNyQ3NBLWVBd3ZZc3hNaVFvcTY2UTZia09xbHhiY0FQVUNsbVRWelhjeGpXdktmWk0yNG5mMkY1SDlYbUlNblhOX0ZOQVVvazhqak9IeXpOeGZScmFLRXRMUUdabDAtQ2lLcw?oc=5", "source_name": "Stocktwits", "published_at": "2026-07-12T20:19:35+00:00", "published_display": "12 Jul 2026 20:19", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Novavax options trading jumps to highest in months By Investing.com", "summary": "Novavax Inc. (NVAX) experienced a significant surge in options trading volume, reaching its highest levels in months on Friday. Call options hit a peak not seen since April 2024, while put options recorded their highest volume since December 2025, with two specific put options do", "url": "https://ng.investing.com/news/stock-market-news/novavax-options-trading-jumps-to-highest-in-months-93CH-2595332", "source_name": "Investing.com Nigeria", "published_at": "2026-07-10T17:44:00", "published_display": "10 Jul 2026 17:44", "sentiment": "negative", "sentiment_pct": 38, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Novavax options trading jumps to highest in months", "summary": "Novavax Inc. experienced a significant surge in options trading volume, with 13,629 contracts traded by Friday afternoon. Call options reached their highest level since April 2024, and put options saw their highest volume since December 2025. This increased activity was predomina", "url": "https://www.investing.com/news/stock-market-news/novavax-options-trading-jumps-to-highest-in-months-93CH-4786599", "source_name": "Investing.com", "published_at": "2026-07-10T16:41:07", "published_display": "10 Jul 2026 16:41", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Enterprise value to EBIT forward of Novavax, Inc. \u2013 BMV:NVAX", "summary": "This page from TradingView provides financial information for Novavax, Inc. (BMV:NVAX), specifically focusing on its enterprise value to EBIT forward. It indicates that the market is currently closed with no trades. The site also lists various other financial data, news, and comm", "url": "https://www.tradingview.com/symbols/BMV-NVAX/financials-statistics-and-ratios/enterprise-value-ebit-fwd/", "source_name": "TradingView", "published_at": "2026-07-10T14:41:07", "published_display": "10 Jul 2026 14:41", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Novavax (NVAX) Leaves Russell Growth Indexes, Is The 32% Undervaluation Case Convincing?", "summary": "", "url": "https://finance.yahoo.com/markets/stocks/articles/novavax-nvax-leaves-russell-growth-051516804.html", "source_name": "Simply Wall St.", "published_at": "2026-07-10T05:15:16+00:00", "published_display": "10 Jul 2026 05:15", "sentiment": "positive", "sentiment_pct": 58, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Novavax (NVAX) Dropped From Major Russell Growth Indices And Why It Matters", "summary": "", "url": "https://news.google.com/rss/articles/CBMioAFBVV95cUxOS2JoeHdWZWQ4T1VvU2N0RFRnNWZYaE1hODZTTURNbGdPSjBQejRCNHJ2Q0dkRHZ3THlHYlJFS2J6NnU2WTNHSi11R3R6ZXJxc1FwOGNlS0xKT1dyZVZDckc1VVVWT1NSNVRvalZYcGhaVnZCM3N0MFNydDRaanJKbWtEMjEtVXR6czRMVzh2MmFoN2U2MGprTEZSWW5rOEhh?oc=5", "source_name": "Market source", "published_at": "2026-07-10T03:24:00+00:00", "published_display": "10 Jul 2026 03:24", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Novavax Inc. stock outperforms competitors despite losses on the day", "summary": "Shares of Novavax Inc. (NVAX) fell 1.16% to $9.35, despite outperforming competitors on a mixed trading day where the NASDAQ Composite rose and the Dow Jones Industrial Average fell. The stock closed 21.89% below its 52-week high of $11.97, achieved on February 26th.", "url": "https://www.marketwatch.com/data-news/novavax-inc-stock-outperforms-competitors-despite-losses-on-the-day-1a5aa003-0d756f5efda7?mod=goog_fin_scmw", "source_name": "MarketWatch", "published_at": "2026-07-08T21:24:00", "published_display": "08 Jul 2026 21:24", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Novavax (NVAX) Suffers a Larger Drop Than the General Market: Key Insights", "summary": "Novavax (NVAX) experienced a larger daily drop of -1.16% compared to the S&P 500's -0.28%, despite recent gains in the Medical sector. The company is set to report earnings with a projected EPS of -$0.36 and revenue of $50.04 million, significantly down from the prior year. Howev", "url": "https://finance.yahoo.com/markets/stocks/articles/novavax-nvax-suffers-larger-drop-214502218.html", "source_name": "Market source", "published_at": "2026-07-08T17:45:00", "published_display": "08 Jul 2026 17:45", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 69, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Novavax Inc. stock underperforms Tuesday when compared to competitors despite daily gains", "summary": "Novavax Inc. (NVAX) shares increased by 1.18% to $9.46 on Tuesday, despite a general market downturn where the NASDAQ Composite fell 1.16% and the Dow Jones Industrial Average fell 0.25%. The stock is still 20.97% below its 52-week high of $11.97, reached on February 26th. This p", "url": "https://www.marketwatch.com/data-news/novavax-inc-stock-underperforms-tuesday-when-compared-to-competitors-despite-daily-gains-8ae5bd92-c8906c390031?mod=mw_quote_news", "source_name": "MarketWatch", "published_at": "2026-07-07T17:26:00", "published_display": "07 Jul 2026 17:26", "sentiment": "negative", "sentiment_pct": 39, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Novavax Inc updates Covid-19 vaccine plans as investors weigh long-term prospects", "summary": "Novavax Inc is adjusting its Covid-19 vaccine strategy, focusing on updated formulations and potential combination vaccines, as it navigates the shift from emergency pandemic demand to a more regular, seasonal vaccination market. Investors are closely watching regulatory decision", "url": "https://www.ad-hoc-news.de/boerse/news/ueberblick/novavax-inc-updates-covid-19-vaccine-plans-as-investors-weigh-long-term/69715214", "source_name": "AD HOC NEWS", "published_at": "2026-07-07T15:13:57", "published_display": "07 Jul 2026 15:13", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "regulatory", "event_label": "Regulatory and legal", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Novavax, Inc. (NVAX) Is a Trending Stock: Facts to Know Before Betting on It", "summary": "Novavax (NVAX) has been a highly searched stock recently, with its shares returning +8.5% over the past month. The company currently holds a Zacks Rank #1 (Strong Buy), indicating potential near-term outperformance based on positive earnings estimate revisions. Despite this, proj", "url": "https://sg.finance.yahoo.com/news/novavax-inc-nvax-trending-stock-130006050.html", "source_name": "Market source", "published_at": "2026-07-07T13:13:57", "published_display": "07 Jul 2026 13:13", "sentiment": "positive", "sentiment_pct": 64, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Does Novavax\u2019s (NVAX) Russell Exit Quietly Recast Its Partnership-Driven, Royalty-Focused Equity Story?", "summary": "Novavax (NVAX) was removed from several Russell growth indices on June 27, 2026, which may influence institutional investor behavior. This expert analysis explores how the index removal could reshape the perception of Novavax's partnership-driven, royalty-focused business model, ", "url": "https://www.sahmcapital.com/news/content/does-novavaxs-nvax-russell-exit-quietly-recast-its-partnership-driven-royalty-focused-equity-story-2026-07-05", "source_name": "Sahm", "published_at": "2026-07-07T06:39:56", "published_display": "07 Jul 2026 06:39", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "If You Invested $1,000 in Novavax Inc (NVAX)", "summary": "This article analyzes the historical performance of investing $1,000 in Novavax Inc (NVAX) over 1, 5, and 10 years, detailing significant fluctuations including a +2383.5% return in 2020 and sharp declines in other years. It also provides an overview of Novavax as a biotechnology", "url": "https://www.stocktitan.net/tools/stock-return-calculator/NVAX", "source_name": "Stock Titan", "published_at": "2026-07-06T03:10:16", "published_display": "06 Jul 2026 03:10", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Novavax stock holds the focus as investors await the next catalyst.", "summary": "Novavax (NVAX) stock remains a Nasdaq-listed vaccine company, with its shares primarily influenced by updates on commercialization, regulatory progress, and cash utilization. The article emphasizes that future market reactions will likely stem from company updates regarding deman", "url": "https://www.ad-hoc-news.de/boerse/news/ueberblick/novavax-stock-holds-the-focus-as-investors-await-the-next-catalyst/69680115", "source_name": "Ad-hoc-news.de", "published_at": "2026-07-03T13:40:11", "published_display": "03 Jul 2026 13:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "regulatory", "event_label": "Regulatory and legal", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Novavax (NVAX) Stock Moves 1.36%: What You Should Know", "summary": "Novavax (NVAX) stock recently moved up 1.36%, closing at $9.59. This movement contrasts with a prior 7.25% loss over the past month for the vaccine maker. Analysts anticipate a significant year-over-year decline in earnings and revenue for Novavax's upcoming report and the full y", "url": "https://finance.yahoo.com/markets/stocks/articles/novavax-nvax-stock-moves-1-214503068.html", "source_name": "Market source", "published_at": "2026-07-02T21:39:19", "published_display": "02 Jul 2026 21:39", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Novavax Inc. stock underperforms Thursday when compared to competitors despite daily gains", "summary": "Novavax Inc. (NVAX) shares gained 2.96% on Thursday, closing at $9.74. Despite this daily increase, the stock underperformed compared to its competitors, even as the Dow Jones Industrial Average rose. This marked the fifth consecutive day of gains for Novavax stock.", "url": "https://www.marketwatch.com/data-news/novavax-inc-stock-underperforms-thursday-when-compared-to-competitors-despite-daily-gains-fa8f491d-5a7723161bbe?mod=mw_quote_news", "source_name": "MarketWatch", "published_at": "2026-07-02T17:24:00", "published_display": "02 Jul 2026 17:24", "sentiment": "positive", "sentiment_pct": 60, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "(NVAX) as a Liquidity Pulse for Institutional Tactics", "summary": "This article analyzes Novavax Inc. (NASDAQ: NVAX) with a strong overweight bias based on robust sentiment across all time horizons. It highlights an exceptional 58.0:1 risk-reward setup, targeting a significant gain for investors. The analysis includes institutional trading strat", "url": "https://news.stocktradersdaily.com/news_release/91/NVAX_as_a_Liquidity_Pulse_for_Institutional_Tactics_070126070202_1782946922.html", "source_name": "Stock Traders Daily", "published_at": "2026-07-01T19:02:00", "published_display": "01 Jul 2026 19:02", "sentiment": "positive", "sentiment_pct": 80, "event_type": "liquidity", "event_label": "Balance sheet", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "ETFs Investing in Novavax, Inc. Stocks", "summary": "This article lists various ETFs that include Novavax, Inc. (NVV1) stocks in their holdings. The ETFs are sorted by market value and provide data such as market value, weight of NVV1 in the ETF, issuer, management style, focus, expense ratio, AUM, price, change, relative volume, a", "url": "https://www.tradingview.com/symbols/BX-NVV1/etfs/", "source_name": "TradingView", "published_at": "2026-06-29T19:10:43", "published_display": "29 Jun 2026 19:10", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Novavax Inc. stock outperforms competitors on strong trading day", "summary": "Novavax Inc. (NVAX) shares rose 5.41% on a strong trading day, closing at $9.36. This performance outpaced the broader market, with the NASDAQ Composite Index and Dow Jones Industrial Average also seeing gains. This marks the second day of consecutive gains for Novavax stock.", "url": "https://www.marketwatch.com/data-news/novavax-inc-stock-outperforms-competitors-on-strong-trading-day-5ea99820-3c8e90419cd3?mod=goog_fin_scmw", "source_name": "MarketWatch", "published_at": "2026-06-29T17:29:00", "published_display": "29 Jun 2026 17:29", "sentiment": "positive", "sentiment_pct": 70, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Novavax, Inc.(NasdaqGS: NVAX) dropped from Russell 3000E Growth Benchmark", "summary": "Novavax, Inc. (NasdaqGS: NVAX) has been removed from the Russell 3000E Growth Benchmark. This news comes amidst other recent company updates, including presentations at healthcare conferences and its first-quarter 2026 earnings report, which showed narrower-than-expected net loss", "url": "https://www.marketscreener.com/news/novavax-inc-nasdaqgs-nvax-dropped-from-russell-3000e-growth-benchmark-ce7f5fdedb81f326", "source_name": "www.marketscreener.com", "published_at": "2026-06-29T03:13:04", "published_display": "29 Jun 2026 03:13", "sentiment": "negative", "sentiment_pct": 33, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Novavax boosts efficiency and productivity with ServiceNow", "summary": "Novavax partnered with NTT DATA to upgrade its ServiceNow platform, aiming to improve operational efficiencies and accommodate rapid growth, particularly following the success of its COVID-19 vaccine. The transformation involved upgrading to the \"Tokyo\" release, establishing a co", "url": "https://www.nttdata.com/en-us/insights/case-studies/novavax-boosts-efficiency-and-productivity-with-servicenow", "source_name": "NTT Data", "published_at": "2026-06-27T02:40:47", "published_display": "27 Jun 2026 02:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Enterprise value to revenue forward of Novavax, Inc. \u2013 SIX:NVAX", "summary": "This article briefly reports on the enterprise value to revenue forward for Novavax, Inc. (SIX:NVAX). It provides basic financial data and links to various tools and resources available on the TradingView platform related to market analysis. The content is sparse, primarily focus", "url": "https://www.tradingview.com/symbols/SIX-NVAX/financials-statistics-and-ratios/enterprise-value-sales-fwd/", "source_name": "TradingView", "published_at": "2026-06-27T02:38:59", "published_display": "27 Jun 2026 02:38", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "How Investors May Respond To Novavax (NVAX) Shareholder Revolt Over Pay And Board Governance", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-06-26T22:17:30+00:00", "published_display": "26 Jun 2026 22:17", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Enterprise value to EBITDA forward of Novavax, Inc. \u2013 SIX:NVAX", "summary": "This article examines the enterprise value to EBITDA forward for Novavax, Inc. (NVAX) on the SIX Swiss Exchange. It provides financial transparency but does not offer specific values or analysis. The brief page is part of a larger financial data platform.", "url": "https://www.tradingview.com/symbols/SIX-NVAX/financials-statistics-and-ratios/enterprise-value-ebitda-fwd/", "source_name": "TradingView", "published_at": "2026-06-26T22:40:06", "published_display": "26 Jun 2026 22:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Novavax Inc. stock underperforms Friday when compared to competitors despite daily gains", "summary": "Novavax Inc. (NVAX) shares rose 3.74% on Friday, closing at $8.88, despite a broader market downturn with the NASDAQ Composite and Dow Jones Industrial Average both falling. This gain ended a two-day losing streak for Novavax, though the stock was noted to underperform when compa", "url": "https://www.marketwatch.com/data-news/novavax-inc-stock-underperforms-friday-when-compared-to-competitors-despite-daily-gains-ce1685b1-20db0dc452a3?mod=mw_quote_news", "source_name": "MarketWatch", "published_at": "2026-06-26T21:40:05", "published_display": "26 Jun 2026 21:40", "sentiment": "negative", "sentiment_pct": 40, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Enterprise value to revenue forward of Novavax, Inc. \u2013 NASDAQ:NVAX", "summary": "This article focuses on the enterprise value to revenue forward metric for Novavax, Inc. (NASDAQ: NVAX). The provided content is from TradingView and includes financial data and stock market information for the biotechnology company.", "url": "https://www.tradingview.com/symbols/NASDAQ-NVAX/financials-statistics-and-ratios/enterprise-value-sales-fwd/", "source_name": "TradingView", "published_at": "2026-06-26T20:40:06", "published_display": "26 Jun 2026 20:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Investors Heavily Search Novavax, Inc. (NVAX): Here is What You Need to Know", "summary": "", "url": "https://news.google.com/rss/articles/CBMiowFBVV95cUxNNXU5a3RtLWNhaTR0dVVzczlGdGRnLWdQQlM1MzQ1WlFYeVRvejNmeXNzVkdoNGZtNXU1TVAzYkxJZU9Pb2F6SU1KQkhnU0s5Ym5MUzVYRnpzRWowVkh2Z1JtM05oam00Q2txZ1h3ZXBQRE5lRHgyUEd3b0pxLTZvWm5xNHV5QkttUHd4eURjMnhWQ056Z0ZOWDB0Z1dtTkpIQjRJ?oc=5", "source_name": "Market source", "published_at": "2026-06-23T07:00:00+00:00", "published_display": "23 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Novavax (NVAX) Stock Falls Amid Market Uptick: What Investors Need to Know", "summary": "", "url": "https://news.google.com/rss/articles/CBMimgFBVV95cUxNR0R0NjJoYUc5ZnZRLXFBZGRJSzJsS25udDFjOVBsX2l1bmIyLVFMX2xWNjZoTzBpY21JWUFFb2M4aElUUFVkTGFpdXl6SWUta3M2dHpvTEl4cHJfSTBVN0p3Q3d0RGY2TnJ5QW5iU2dGTmU5dHJ5MXZ0SDdUNHJVdnVHbmZMSGJUeWF4TXdqdXdQS3lOcnNaOUxn?oc=5", "source_name": "Market source", "published_at": "2026-06-18T07:00:00+00:00", "published_display": "18 Jun 2026 07:00", "sentiment": "negative", "sentiment_pct": 22, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Novavax (NVAX) Stock Slides as Market Rises: Facts to Know Before You Trade", "summary": "", "url": "https://news.google.com/rss/articles/CBMingFBVV95cUxPU3Q1eE5WdXBtNjdhR2daMzljZ3ZObE4tSmJCNlhfYWtwamdySl91eTF4eENQQ3dVTFZZRlg1Q3c5WmFtUG04UzZtVjRnY1FscnJvSC1IV0FFV21NN09DMUlMcGxMMEYxc1dKVXN4NDIwa3JHdjUycHEyeXJwMDFjR0ZOQklibkRBM0tfbTBRckxxMDBwajc0dTdwZGJVUQ?oc=5", "source_name": "Market source", "published_at": "2026-06-12T07:00:00+00:00", "published_display": "12 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Novavax Inc stock (US6707721049): Analyst consensus points to hold as NVAX trades near 11 USD", "summary": "", "url": "https://news.google.com/rss/articles/CBMiygFBVV95cUxPNExjdEtwQVR4Q1RmeUdIM0JOdmhLenRfVXBvWTc1T0Mta1Q0T2ZNTm5WRVVSSFp3SmpnUDNNWU1nd0VFejVsWldLV1phdV9uY05vMmxqZGJKazRGSFZCTk1fVlhJQlVuMGRyMXFyUDdiYUM1VGVOS09Vbmw2U0p6b2NwRXItUU9rbmd2MThaaDVfcExwWmtwS0RUa2wyVEhFSVhGc3NFcGV2ZHR5cTVxOGpHZllYTkFXY3Uzb1hzYUNrcVEycHlyYmhn?oc=5", "source_name": "Ad Hoc News", "published_at": "2026-06-01T07:00:00+00:00", "published_display": "01 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Novavax Inc stock (US6707721049): shares trade around USD 10 after recent volatility and licensing f", "summary": "", "url": "https://news.google.com/rss/articles/CBMiyAFBVV95cUxOLVE5bWJUcHlrUHFlVkpDN1UwcWFjYWViNFNEZTA1S0kxSEt5dVR1OFBTeDhuZk11RUNyNjFHSWJnYXlNdERTNEVrZzhMcmJCcUtBRnRTcVUwTkdDcTJZdHdzMkN0OG9LS1dqOTVyWWFBTUNGbERVck9wNW5lU1JzUXEycDBpT3lvdENPVWNNdndDdmdlZWo2YVlORlVwS2xjMGZ4aXlqb0dlWkZSN3hZeWZZTmtteURJWDBFS0ExNTlsYVZ0eVFNSQ?oc=5", "source_name": "Ad Hoc News", "published_at": "2026-05-29T07:00:00+00:00", "published_display": "29 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Novavax Inc stock (US66987V1098): NVAX trades at $11.09 on Nasdaq", "summary": "", "url": "https://news.google.com/rss/articles/CBMivAFBVV95cUxPclBSWnlWa18tSkM0cTRTZGlqLVUyV0U4Y1I5LTBieU0xTEtxdEdsYkxsWndUdlpmd1duLV9pZHNsT0JEbllIRTI1U1V0Q0hEN3dwUFotb0VVWHNHRDUxZGNiWXE0R29uTFRqMGdtWVFmSkJ3WWVQY2JYaXdpMDI3aTN1SlF3b1RTMnVtSXpwd2xRenRiaFNiRnVzZk9YNHV4b2ZDc3ZUTzlMTGhGNE9aNFdGa0ZKaldTeDN2aQ?oc=5", "source_name": "Ad Hoc News", "published_at": "2026-05-28T07:00:00+00:00", "published_display": "28 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Why Novavax (NVAX) Stock Is Trading Up Today", "summary": "", "url": "https://news.google.com/rss/articles/CBMimwFBVV95cUxPeElVSURka1VqSl94NEhLNUM2MDhpV3d4MkZpS3RPbWNaSjF5QVhSS21STDRRNFZZck9DSnNranhXRklnenF3dW5neDFON2tsdW1JUmxwMzFaUzlwWFRqZ3FMVV82eDVMYzAzWUF0N3VLSmhnYndST21BN1NTa2poVm95MHhoRU5HWjNHR1ZjcW9SdjhYODVDZkdSSQ?oc=5", "source_name": "Market source", "published_at": "2026-05-26T07:00:00+00:00", "published_display": "26 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Novavax Inc stock (US66987V1098): earnings volatility and Covid-vaccine hopes in focus", "summary": "", "url": "https://news.google.com/rss/articles/CBMixgFBVV95cUxQRGpPRGNaOWE3bXFiZUZMaWZ5ZmNlZ1ZPdUdMYkRvLWE5alI5MXdRSnZaQXlQckNTTUMtYlNyVGlIc1VpMTJNMmN3RWxJUU83anZPQkRLRHdUTjJmRWxjd3kzdk1QTTRKcklIcGRGU1N4bjZ4Y3FVZTR2eTh4c2w1UUlZYlYxLVF5M0dzbHdQdTlNYVV2OGZZZ1ZuRmxHUWlsSGgzU0lJMGNTSEVFX2tCMGgzRnVaWkZNaGhtUFVNUVI4RFVkT0E?oc=5", "source_name": "Ad Hoc News", "published_at": "2026-05-17T07:00:00+00:00", "published_display": "17 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Novavax stock (US66987V1098): Latest developments and business update", "summary": "", "url": "https://news.google.com/rss/articles/CBMiwwFBVV95cUxNZmlwR0JCT2hid25JV1VkeVNBU3JwUWF6UlpQSURnNndaNXNGS1dvaTdxZTNtNWNKcDlXNlp2OTVVTzkzN3lOeTlfRC15eVVUdFd3dVhjODRqN3B0SUdHaVBlaktXNXdyOGNRYmJvR014T25mSjlWSFlsS1hLLW1HNjl0amhYMWlkQ2tDZ3FzdmNmVEp5SEM4QnhUVS02WjY2NHhZUGdlb19OUzY5b0hTaGpTUkVjT183Q2cxSU1OaXhVT3c?oc=5", "source_name": "Ad Hoc News", "published_at": "2026-05-14T07:00:00+00:00", "published_display": "14 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Novavax (NASDAQ:NVAX) Surprises With Strong Q1 CY2026, Stock Soars", "summary": "", "url": "https://news.google.com/rss/articles/CBMiowFBVV95cUxQQUVPRXZYeS1UaE5JYmRiR0tINk9hVFFnTG1NTHBkSlNsVW1pN3RlclBzQW50MXZLTzBwRDkxenBnQlZDU1A1UWNlTWluSDRUMm1pVHFSamtxTEMzOVFzNi1wQTAxTWRhRnU4YkJEY0FwemR6d25vc3ZWTEZwN19XYzZBUURGM3h3QjBla29ETE12NjE5N3BEUmxxdjYzZVN2dlow?oc=5", "source_name": "Market source", "published_at": "2026-05-06T07:00:00+00:00", "published_display": "06 May 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Is It Time To Reconsider Novavax (NVAX) After A 95% Five Year Share Price Fall", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-05-05T07:00:00+00:00", "published_display": "05 May 2026 07:00", "sentiment": "negative", "sentiment_pct": 34, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Is Novavax, Inc. (NVAX) A Good Stock To Buy Now?", "summary": "", "url": "https://news.google.com/rss/articles/CBMilwFBVV95cUxQUk1xRnVDRTlqZVBLMHFCUjdhcTVwckFDWWo1VWx4emZmUDVqcEhET0c1VjFnYzhlaFByU1p3VW1pbFVQcW16YTNaSzQzVGEybkR1X3ZFSGNia0NVS0w5Y3lpSlRFTGdiZnFwWHRxQTVmQ1p1elNqYTVjRnJycmUzQ2VraTR6MDJycXBVRVk5UGs4UnpYTEY0?oc=5", "source_name": "Market source", "published_at": "2026-04-30T07:00:00+00:00", "published_display": "30 Apr 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Novavax (NVAX) Beats Stock Market Upswing: What Investors Need to Know", "summary": "", "url": "https://news.google.com/rss/articles/CBMinAFBVV95cUxQaHAwQ0RVN181VEpKMUo2WUZteDhPUm82TDFnbzFoVHBVVnhxbkhrT2h0aGFNM1AwMkpmRFVvbUgxM2xzVjRaOXlhNFk5Z1NRaEtUVmNZcjlJM3lHRldxczJvRWZhektZcnlGdWdsYVdWVE9wN1N2dVlUY3dUcGVpRU13RnpQcHdsZ21PZ3ZTdmdqZmNQaDZFSTZhbFA?oc=5", "source_name": "Market source", "published_at": "2026-04-09T07:00:00+00:00", "published_display": "09 Apr 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "AMN Healthcare Services, DaVita, Bristol-Myers Squibb, Novavax, and AbbVie Shares Plummet, What You Need To Know", "summary": "", "url": "https://news.google.com/rss/articles/CBMi-gFBVV95cUxPZmJKQ3l2S2FkYjlsd0xiQWUwX1V5d3R2cEMzblBrVmNTUEdtdWFndkl6UnAyOTVQYW96VGdiQzlaX3dwQ0FjSUNHVE9mSy1kLTlhX29HUmFfcG55ZlRRV2lfcGl2S2l5ZXc0TUZwcmFxRGFHVjJyWW9EMXk4UVFWRUxQMEZybElFTll6NjNsNUxKcUJ6cEE2aTZPYXpMYXhYRm51LTRlRHp2RXIzQjFfSG1Wc3pVcFkyRVZaUjduTjFOWlZ5TmV1Q1VKWUdPREtlbW5sX3c3MkltOWVXRWlHMEdUSnBBTllFRjQ3bFkwSndnc2FiZFlkOHhB?oc=5", "source_name": "StockStory", "published_at": "2026-04-02T07:00:00+00:00", "published_display": "02 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Reassessing Novavax (NVAX) After Recent Share Price Rebound And Valuation Signals", "summary": "", "url": "https://news.google.com/rss/articles/CBMiiwFBVV95cUxPa0g1TTk2RjU0X3FEdGcxTjJpWDhzQ04ydzZ0SEt3c0FMTm4zdWM2RzdNOUFYanFHb3kzZXhpQlBmbjZ3TXIyWVo2WDdYQ3ZycmtTS0Zya3oxR1VDS1BiYWFGYTRyYTZ4dFZjV19tbXg4OXozcHQ3RHlKb3REY2dYa3M2VmRmVUt6aWIw?oc=5", "source_name": "Market source", "published_at": "2026-01-23T08:00:00+00:00", "published_display": "23 Jan 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Novavax Pfizer Licensing Deal Puts Matrix M And Valuation In Focus", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-01-22T08:00:00+00:00", "published_display": "22 Jan 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Improved Revenues Required Before Novavax, Inc. (NASDAQ:NVAX) Stock's 32% Jump Looks Justified", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-01-14T08:00:00+00:00", "published_display": "14 Jan 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Novavax, Inc.'s (NASDAQ:NVAX) latest 12% decline adds to one-year losses, institutional investors may consider drastic measures", "summary": "", "url": "https://news.google.com/rss/articles/CBMi2AFBVV95cUxNSnQ5UWQteFhYbXJjSzRqZUpweGQ2czJOVTBKTGdla3dSSUV0WkJYdEtkNVpaTThwWEdZbWtWSGNNS055ZTFfZ2NOQXQ0ZlFsSG1zSFlPeGhRVWVHYWEtUWxUSE13V09PMm91WkFnZ1VScmtObFFPWVBkbE9RS3JpUFBHRldnOUkzazFHeXVXT1A5eXc2eXdmaVpZV2E3SjdEQWlVMFdXUmtLUFlFME9YZHRsXzNacmhXbzUzNjRtMUF3eU1mS1NwT2E3UHJnZ1BjZGIyZXUxek_SAd4BQVVfeXFMT3ZhNlVRM2lUd0JrcXQtYm4zZ25EOGhWNEM3NVNHS0ZSWUY2NVNualozZjRPSHRhNVZaWlAyYXlhdlpVTmFBbWRNNXFnXzItV05CNzNSN2NFTjRxTE1ER2VLVFg1UVQ1WjhaRHJ4MFFhLTV0eEJtM1FMQnBTaFhOYU9pLUxNTHc2VEtuM3FLQkxWZXNQTkVVOXZ4VVRsT051YndtOFVDMkpNUC1sRDFzYXRSU0w2MFF4amM1b3lYZERDbm9meW9OSmpydWYzM0cwb3pRZXJhbndvajhVbF9n?oc=5", "source_name": "simplywall.st", "published_at": "2025-08-03T07:00:00+00:00", "published_display": "03 Aug 2025 07:00", "sentiment": "negative", "sentiment_pct": 18, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Novavax sinks on concerns about COVID vaccine maker's prospects", "summary": "", "url": "https://news.google.com/rss/articles/CBMivgFBVV95cUxNOVFTcHhvcUQ5YTd5cFpzNXBWcjJvZUZldlptdjNSMkxQZHItRUM4RGlnbEt0MTVuUjN6RnZaQ2dMdzFjSDUwVWt5ZklObERVU1p0X2x5cHMwb1JBWHBwdmVjaGF3a2dJNUUwdXF4Qk1jZi1JcVFsREROMXhGVDAtMWZWeVVIRkRkZUFiNldLYjE2R0xsbjhOa2VMelpMMlVGd0NERkY0a0ljQ21iZ3QwZ292MjJ2blctc05lcU9n?oc=5", "source_name": "Reuters", "published_at": "2023-03-01T08:00:00+00:00", "published_display": "01 Mar 2023 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Novavax confident Covid vaccine will receive FDA authorization in June after delays", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "CNBC", "published_at": "2022-05-13T07:00:00+00:00", "published_display": "13 May 2022 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "COVID-19 vaccinemaker Novavax faces manufacturing setback", "summary": "", "url": "https://news.google.com/rss/articles/CBMingFBVV95cUxOeEJNQUIzWjBEREF3em1Sc2k3ZzBQMTdsRWtkZWZsTEpFT0NsWnMxMmlVMU51NWJ4bGs0TjhnNk1aMHp5M0k3NVNVWnRITldLMm56X0NQcFVobFJmYUNac1BmalN4VEJtem5zTFpfM1BOVFBkbHZ5TXRCLVRiZVpDbW0zZ0lTSEpjRzQwNC16LVZFZzZ6dmxKZ3gxbTZoQQ?oc=5", "source_name": "Science | AAAS", "published_at": "2021-08-06T07:00:00+00:00", "published_display": "06 Aug 2021 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "After a Rocky Start, Novavax Vaccine Could Be Here by Summer (Published 2021)", "summary": "", "url": "https://news.google.com/rss/articles/CBMib0FVX3lxTFBrOTVsT3RUTmxseDVIWUFabzI4NFJyUnpHbHlCR19WUTlJWHJBRldUY2FnVGhYY0JXT1hLZ3ZiMmUxTUcyT1VzV3Bmb2I1ME9CZklBQ0Q0akhueEduZFpvbS11d2U0ZEZNdTkyRXNMOA?oc=5", "source_name": "The New York Times", "published_at": "2021-02-04T08:00:00+00:00", "published_display": "04 Feb 2021 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Novavax bosses cash out for $46 million with COVID-19 vaccine trials still under way", "summary": "", "url": "https://news.google.com/rss/articles/CBMi9AFBVV95cUxNQl9FU2RJWGUzTlp0UUdudVRWd3p1Wml0MnViQ0U5ZnJ3czVWU1p4NWRHTGU2eUJScGpQMmVtVGxYSENXSTkwRUtkODJBeWREallpQWhLeUxDSklZdnUzMTE2TDUwV2pvdE96WWdSQllXd3RPVEtwOTF3VFZaX0tjcUF3Z2tnTjV5dEN0c3c5Z1JyRlVyamZDcm1JSXVLQ3lGejV3MDExYnZWbUVYYWFHMW5nakN6ZGpiU1JHcnM1czlyZzNFNHJIa0tMNkdSRHMybWF2dVJFTEc0am9GNi16aTFNdFFVYnotU3phcGRzX1QwYkho?oc=5", "source_name": "Reuters", "published_at": "2021-01-11T08:00:00+00:00", "published_display": "11 Jan 2021 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "liquidity", "event_label": "Balance sheet", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}], "industry": [{"title": "Unpacking Q1 Earnings: Incyte (NASDAQ:INCY) In The Context Of Other Biotechnology Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMinAFBVV95cUxOZExLRk1BSFNPMnpMdEFEWjNtbWlkZUQ1aHJHZEtMZHJHZWZDZUI0ck1FM2JqWG9ncDRSNGxEWHZLemZualBEY3BVVzdiUmZiVmxqMFdnbEczbEpvTFBscnA3YVVMWmQ3TkFsVjBDZzl6VEZQanh1UkRaS2hiRTNPbGFwajRSV1A1amFKcnFhcFVITHdydjJpblVRTWI?oc=5", "source_name": "Market source", "published_at": "2026-07-13T12:30:39+00:00", "published_display": "13 Jul 2026 12:30", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "There May Be Reason For Hope In Puma Biotechnology's (NASDAQ:PBYI) Disappointing Earnings", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-05-15T07:00:00+00:00", "published_display": "15 May 2026 07:00", "sentiment": "negative", "sentiment_pct": 34, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Puma Biotechnology's (NASDAQ:PBYI) Conservative Accounting Might Explain Soft Earnings", "summary": "", "url": "https://news.google.com/rss/articles/CBMirgFBVV95cUxNZXcyN1VKc0J0RTFtSER6TGRSZm8xSWs2c0paem5paDd3V0J1cjF6ajhFb29tRFpUWWpxYUhzZjFkSXhYQ0lBNTVlbTdCRERpSXNjaGpDajFPOVlpRS1qV2xHMTRHS2pjVVBZMWFfNzItWE9FeENtQ2duMUxVQm5kOG41eVlrNUpObXp2VlhfekdhMVh2X0hjN3ZFZThZNUdWakFLUXJ4aFBVN2JyR2c?oc=5", "source_name": "Market source", "published_at": "2026-05-14T07:00:00+00:00", "published_display": "14 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Puma Biotechnology, Inc. (NASDAQ:PBYI) Analysts Are Pretty Bullish On The Stock After Recent Results", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-05-11T07:00:00+00:00", "published_display": "11 May 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Earnings Update: Here's Why Analysts Just Lifted Their Puma Biotechnology, Inc. (NASDAQ:PBYI) Price Target To US$5.00", "summary": "", "url": "https://news.google.com/rss/articles/CBMingFBVV95cUxPSUN3RjZYMEJ2VUdKQjJpRkZaUXRzM2NTa05WWmlmWHJnZDlJeUpTdFM5Wmk0SUhjclU2dldTZFIyRmZZeGJSNGM2SUNiSGJSYjh1VjYyR0hPZ2FJbWdsbHExYlhwMW1HRTZ0NUxwQzU1b2g4MGpwSHdoMkdIOUtqOXBBYk92LVk2cEFZMzVISjB3c04ydVBEYWw2cVVsdw?oc=5", "source_name": "Market source", "published_at": "2026-05-11T07:00:00+00:00", "published_display": "11 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Q4 Earnings Highlights: Regeneron (NASDAQ:REGN) Vs The Rest Of The Biotechnology Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMirAFBVV95cUxNWW9GYm5uRzlBX2ZiZXA3RkdDXzJhaFd2N1ZwR21jaXhiRkZQSTNHT0hMaUFjSGl6VXZfOURKemF2bWlFS1hKTXBjZUw4amdVQ0I4QlVnNmFkY1VTQ25pUjBiZGNDUE9QdWdOZHAxV1I1ejN6UE9WdGpseUdrMVA5MXBXWXJmWDBkZUdWUkxpOURCdlZlbDlQR3M5cjAzaDFtakFNblRTa3c0Q1J6?oc=5", "source_name": "Market source", "published_at": "2026-04-25T07:00:00+00:00", "published_display": "25 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Biotechnology Stocks Q3 Results: Benchmarking Natera (NASDAQ:NTRA)", "summary": "", "url": "https://news.google.com/rss/articles/CBMiswFBVV95cUxPZzZDSEhwNlVYQU9kNXBMMU5ia0FTU0RxRlYwb0I1RERNODN4N0VwRFZWMUY4ODh3eWNkTkp0UERreFlSTllocGk4a2ZKcGlJVjQ4d1dXWlNnYTc5UlNMZm4wc2xITjRQVzhRb3Z5LXllQmhvUHNIaXB3LXk1RUw1WnRPam9wcVE1MXFxSmVzVF9MVmRyMWIwdVkxS1N3MUJZUzByLWxrVDlSSUk4QnNsXzJYbw?oc=5", "source_name": "Market source", "published_at": "2026-04-21T07:00:00+00:00", "published_display": "21 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "A Look Back at Biotechnology Stocks\u2019 Q4 Earnings: Incyte (NASDAQ:INCY) Vs The Rest Of The Pack", "summary": "", "url": "https://news.google.com/rss/articles/CBMi5gFBVV95cUxNWEtsYkktQkxQRHpTMHJOZzJaN09fT3R5aUpjZ0xEQTZXZGlCVUk0alZrVXhIRERNOW9feVJ1X0R4VUI2Q0FjUGIwTWpIRXE2dXpCLW9NdVdoSEE5b0JEM18wN2FQSGdXMDZfOGJ3STJPUmQ2VVBIbUQ5djhTZ01RTmpxLTdKRmdhN0U3RE52N0dEUzh4VFZ5c3dDd0ppZ1VYeGc0Mm5oQlU5TGJlQldpVHpoVjlhdXZ6ek0yaTBuQV9UUjNFT19kWFZ4QVViODkwN2ppOFRQU3lHQ1IxdXhrRkFGS3E0QQ?oc=5", "source_name": "TradingView", "published_at": "2026-03-29T07:00:00+00:00", "published_display": "29 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}], "sector": []}, "total_fetched": 104, "total_relevant": 60, "sentiment_summary": {"positive": 11, "negative": 9, "neutral": 40, "score": 50, "total": 60, "label": "Balanced news tone", "tone": "neutral"}, "classifier": {"primary_event": "general", "primary_label": "Market update", "confidence": 82, "events": [{"event": "general", "label": "Market update", "weight": 22.6, "count": 36}, {"event": "earnings", "label": "Earnings", "weight": 7.7, "count": 16}, {"event": "analyst", "label": "Analyst action", "weight": 2.0, "count": 3}, {"event": "liquidity", "label": "Balance sheet", "weight": 1.45, "count": 2}, {"event": "regulatory", "label": "Regulatory and legal", "weight": 1.1, "count": 2}, {"event": "deals", "label": "Deals and strategy", "weight": 0.55, "count": 1}], "positive_events": 11, "negative_events": 9}, "market_context": {"has_market_context": true, "latest_close": 9.33, "latest_week": "2026-07-10", "one_week_move": -4.2, "four_week_move": 5.1, "twelve_week_move": 5.5, "trend_signal": "1", "trend_label": "Trend active", "trend_tone": "positive", "market_dynamics": -0.024466, "market_dynamics_buy_signal": false, "relative_strength": -4.385128, "fair_value_gap": 12.5, "fair_value_label": "Near fair-value range", "fair_value_tone": "neutral", "expectation_direction": "negative", "expectation_probability": 44.0111, "reaction_label": "Price reacting lower", "reaction_tone": "negative", "market_sentence": "-4.2% over one week, +5.1% over four weeks, trend active, and near fair-value range."}, "interpretation": {"label": "Price moving ahead of tone", "tone": "negative", "classification": "price_leads_news", "summary": "Price is moving more forcefully than the current news tone suggests.", "confidence": 59, "badges": [], "opportunities": [], "risks": [], "event_label": "Market update", "sentiment_word": "balanced"}, "charts": {"sources": [{"label": "Market source", "count": 18}, {"label": "MarketWatch", "count": 7}, {"label": "simplywall.st", "count": 7}, {"label": "TradingView", "count": 6}, {"label": "Ad Hoc News", "count": 5}, {"label": "Reuters", "count": 2}, {"label": "Stocktwits", "count": 1}, {"label": "Investing.com Nigeria", "count": 1}], "tiers": [{"label": "Direct company coverage", "count": 52}, {"label": "Industry context", "count": 8}, {"label": "Sector context", "count": 0}], "events": [{"label": "Market update", "count": 36}, {"label": "Earnings", "count": 16}, {"label": "Analyst action", "count": 3}, {"label": "Regulatory and legal", "count": 2}, {"label": "Balance sheet", "count": 2}, {"label": "Deals and strategy", "count": 1}]}, "insights": [{"label": "Weighted tone", "value": "50/100", "tone": "neutral", "text": "Balanced news tone"}, {"label": "Market reaction", "value": "Price moving ahead of tone", "tone": "negative", "text": "Price is moving more forcefully than the current news tone suggests."}, {"label": "Primary event", "value": "Market update", "tone": "neutral", "text": "82/100 classification confidence."}, {"label": "Company focus", "value": "52", "tone": "positive", "text": "directly relevant articles"}, {"label": "Source quality", "value": "10", "tone": "positive", "text": "high-authority source matches"}, {"label": "Trend context", "value": "Trend active", "tone": "positive", "text": "-4.2% over one week, +5.1% over four weeks, trend active, and near fair-value range."}, {"label": "Latest direct headline", "value": "Neutral", "tone": "neutral", "text": "Novavax (NVAX) Stock Sinks As Market Gains: Here's Why"}], "updated_at": "2026-07-16T08:07:33.597230+00:00", "disclaimer": "Educational market research only. Not financial, investment, trading, tax, or legal advice."}